TransMedics Group, Inc.

TransMedics Group, Inc. is a commercial-stage medical technology company that transforms organ transplant therapy for patients with end-stage organ failure. The company primarily offers the Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system. This system uses proprietary technology to replicate near-physiologic conditions for donor organs outside the human body, preserving them for transplantation. The OCS portfolio includes OCS LUNG for double-lung transplantation, OCS Heart for preserving donor hearts that are unsuitable due to cold storage limitations and for reanimation of donation-after-circulatory-death hearts, and OCS Liver for preserving donor livers from both brain-dead and circulatory-death donors. TransMedics also provides a national OCS program, a turnkey solution for outsourced organ retrieval, and organ management and logistics services including aviation and ground transportation.

TransMedics Group, Inc. is listed on the Nasdaq Global Market (NasdaqGM) under the ticker symbol TMDX. The company's stock is traded in US Dollars (USD). As a US-based company, its financial reporting and market trading are conducted in USD, making it accessible to investors through US stock exchanges.

TransMedics Group, Inc. operates in the Healthcare sector, specifically within the Medical Devices industry. As a medical technology company, it focuses on developing and commercializing innovative devices for organ transplantation. The company's Organ Care System (OCS) is a medical device that addresses critical needs in transplant medicine, positioning TransMedics within the broader healthcare and medical devices landscape.

TransMedics Group, Inc. is headquartered in Andover, Massachusetts, United States. The company serves the United States and global markets. Its Organ Care System (OCS) and related services are used by transplant centers and organ procurement organizations worldwide. The company also operates a national OCS program that provides outsourced organ retrieval and logistics services, including aviation and ground transportation, to support organ transplantation across the US and internationally.

TransMedics generates revenue through the sale and support of its Organ Care System (OCS) portfolio, which includes OCS LUNG, OCS Heart, and OCS Liver devices. Additionally, the company offers a national OCS program, a turnkey solution for outsourced organ retrieval, and provides organ management and logistics services such as aviation and ground transportation, as well as coordination activities. These services are designed to support transplant centers in the efficient retrieval and preservation of donor organs, creating a recurring revenue stream from service fees and device sales.